About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Aurobindo Pharma Net Dips 13.16 Percent in Q2: BSE

by Bidita Debnath on November 8, 2015 at 2:18 AM
Font : A-A+

 Aurobindo Pharma Net Dips 13.16 Percent in Q2: BSE

Pharmaceutical manufacturer Aurobindo Pharma said that it posted a standalone net profit of Rs.340.09 crore for the second quarter of 2015-16 against a net profit of Rs.391.66 crore in the same period last year, showing a 13.16 percent dip.

According to the statement of standalone unaudited results posted on the Bombay Stock Exchange (BSE), the company's total income from operations rose to Rs.2,175.93 crore from Rs.2,007.70 crore while total expenditure increased to Rs.1,690.50 crore from Rs.1,468.66 crore.

Advertisement


On consolidated basis, Aurobindo Pharma posted a net profit of Rs.451.76 crore in Q2 against Rs.372.18 crore in the last quarter, while total income from operations rose to Rs.3,333.43 crore from Rs.2,881.22 crore.

Aurobindo Pharma incurred a total expenditure of Rs.2,650.65 crore in the reviewed quarter on a consolidated basis against Rs.2,333.86 crore in the previous quarter.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
Test Your Knowledge About Chromosomes?
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Most Popular on Medindia

Diaphragmatic Hernia Nutam (400mg) (Piracetam) Loram (2 mg) (Lorazepam) The Essence of Yoga How to Reduce School Bag Weight - Simple Tips Iron Intake Calculator Blood - Sugar Chart Find a Doctor Noscaphene (Noscapine) Indian Medical Journals
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Aurobindo Pharma Net Dips 13.16 Percent in Q2: BSE Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests